Jci_page_head_homepage_01 Jci_page_head_homepage_02
Zhaojun Wang, Jian Hong, Wei Sun, Guangwu Xu, Ningli Li, Xi Chen, Ailian Liu, Lingyun Xu, Bing Sun, Jingwu Z. Zhang
Published in Volume 116, Issue 9
J Clin Invest. 2006; 116(9):2434–2441 doi:10.1172/JCI25826
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6
Suppressing effect of IFN-γ–treated CD4+ CD25 T cells in EAE.

CD4+CD25 T cells were purified from GKO mice and cultured in vitro with or without recombinant IFN-γ for 72 hours in the presence of anti-CD3 antibody. The resulting CD4+CD25high T cells from both groups were purified and subsequently transferred to GKO mice (2 × 106 cells per mouse) at day 9 and day 11 after immunization. CD4+CD25+ T cells purified from naive WT mice (Tregs) were transferred at the same cell number (2 × 106 cells per mouse) and under the same experimental conditions without IFN-γ. GKO mice given PBS instead of cells were included as a reference (PBS). Each group consisted of at least 4 mice. Mice were monitored clinically every day for EAE development and progression. The data are presented as EAE clinical scores.